1.
Record response to call for new astronauts
SILVER SPRINGS, Md., Jan. 30 (UPI) -- GlaxoSmithKline's breast cancer drug Tykerb can now be used in combination with the Novartis cancer drug Femara, the U.S. Food and Drug Administration says.
The FDA Friday broadened approval of Tykerb, generically known as lapatinib, in combination with Femara, or letrozole, to treat hormone positive and HER2-positive advanced breast cancer in postmenopausal women.
HER2, a protein involved in normal cell growth, is found on some types of cancer cells, including breast cancer cells. In hormone positive breast cancer, the presence of certain hormones contributes to breast cancer growth, the FDA said in a release.
"This drug combination of Tykerb plus Femara provides women being treated for advanced breast cancer with an important (oral) treatment option," said Dr. Richard Pazdur, director of the FDA's Office of Oncology Drug Products.
The most commonly reported side effects of the drug combination were diarrhea, rash, nausea and fatigue.
|
|
|
| Additional Science News Stories | |
NEW YORK, Feb. 9 (UPI) --
A man who made his young son run around and do pushups in the New York City snow in his underwear has incited outrage from people who say he is cruel.
|
NEW YORK, Feb. 9 (UPI) --
Macaulay Culkin is in "perfectly good health," his publicist said after the former child star was photographed looking gaunt and disheveled in New York.
|
GREENBELT, Md., Feb. 9 (UPI) --
NASA's Mars Reconnaissance Orbiter has captured the first color image from orbit of the three-petal lander of NASA's 2004 Rover Spirit mission, scientists say.
|
UPI horoscopes for Friday, Feb. 10, 2012.
|
| Stories | Photos | People | Comments |
View Caption
